References
- Koenig AM, Thase ME. First-line pharmacotherapies for depression – what is the best choice? Pol Arch Med Wewn 2009;119:478–86.
- Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. J Am Med Assoc 2002;287:203–9.
- Demling J, Beyer S, Kornhuber J. To sweat or not to sweat? A hypothesis on the effects of venlafaxine and SSRIs. Med Hypotheses 2010;74:155–7.
- Ashton AK, Weinstein WL. Cyproheptadine for drug-induced sweating. Am J Psychiatry 2002;159:874–5.
- Babbott SF, Pearson VE. Sertraline-related night sweats. Ann Intern Med 1999;130:242–3.
- Kiev A, Feiger A. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. J Clin Psychiatry 1997;58:146–52.
- Keller MB, Hirschfeld RM, Demyttenaere K, Baldwin DS. Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol 2002;17:265–71.
- Kim WO, Kil HK, Yoon KB, Yoo JH. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients. Acta Derm Venereol 2010;90:291–3.
- Sadock BJ. Biological therapies Kaplan & Sadock’s Synopsis of psychiatry. 10th ed. Boston, MA: Wolters Kluwer, Lippincott Williams & Wilkins; 2007. p. 1083–91.
- Garber A, Gregory RJ. Benztropine in the treatment of venlafaxine-induced sweating. J Clin Psychiatry 1997;58:176–7.
- Tupker RA, Harmsze AM, Deneer VH. Oxybutynin therapy for generalized hyperhidrosis. Arch Dermatol 2006;142: 1065–6.
- Kowalski JW, Eadie N, Daggett S, lai PY. Validity and reliability of the Hyperhidrosis Disease Severity Scale (HDSS). In: 62nd Annual Meeting of the American Academy of Dermatology. Washington, DC. Poster P198, 6–10 February 2004.
- Stahl SM. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Biol Psychiatry 2000;48:894–901.
- Mago R, Monti D. Antiadrenergic treatment of antidepressant-induced excessive sweating in 3 patients. J Clin Psychiatry 2007;68:639–40.
- Feder R. Clonidine treatment of excessive sweating. J Clin Psychiatry 1995;56:35.
- Leeman CP. Pathophysiology of tricyclic-induced sweating. J Clin Psychiatry 1990;51:258–9.
- Butt MM. Managing antidepressant-induced sweating. J Clin Psychiatry 1989;50:146–7.
- Salmi P, Ahlenius S. Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms. Pharmacol Toxicol 1998;82:122–7.
- Speroff L, Gass M, Constantine G, Olivier S. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial. Obstet Gynecol 2008;111:77–87.
- Medgett IC, Fearn HJ, Rand MJ. Serotonin enhances sympathetic vasoconstrictor responses in rat isolated perfused tail artery by activation of postjunctional serotonin-2 receptors. Clin Exp Pharmacol Physiol 1984;11:343–6.
- Ramage AG, Villalon CM. 5-hydroxytryptamine and cardiovascular regulation. Trends Pharmacol Sci 2008;29:472–81.
- Terazosin: Drug information. UpToDate Waltham, MA: UpToDate; 2011.